Varian Medical Systems has announced three new leadership changes effective October 5, including the promotion of Chris Toth to the newly created role of president and chief operating officer (COO).
Toth currently serves as president of Varian Oncology Systems. In his new role, he will report to CEO Dow Wilson and will oversee Varian's business operations, including its 2021 fiscal goals and strategic plans.
The company also announced that Kevin O'Reilly will replace Toth as senior vice president and president of Varian Oncology Systems. In addition, Stephanie Foster has been named senior vice president of global supply chain operations.
